Cholinergic neuromodulation controls directed temporal communication in neocortex in vitro.
Acetylcholine is the primary neuromodulator involved in cortical arousal in mammals. Cholinergic modulation is involved in conscious awareness, memory formation and attention - processes that involve intercommunication between different cortical regions. Such communication is achieved in part through temporal structuring of neuronal activity by population rhythms, particularly in the beta and gamma frequency ranges (12-80 Hz). Here we demonstrate, using in vitro and in silico models, that spectrally identical patterns of beta2 and gamma rhythms are generated in primary sensory areas and polymodal association areas by fundamentally different local circuit mechanisms: Glutamatergic excitation induced beta2 frequency population rhythms only in layer 5 association cortex whereas cholinergic neuromodulation induced this rhythm only in layer 5 primary sensory cortex. This region-specific sensitivity of local circuits to cholinergic modulation allowed for control of the extent of cortical temporal interactions. Furthermore, the contrasting mechanisms underlying these beta2 rhythms produced a high degree of directionality, favouring an influence of association cortex over primary auditory cortex.
Roopun
Anita K
AK
Institute of Neuroscience, The Medical School, Newcastle University Newcastle, UK.
Lebeau
Fiona E N
FE
Rammell
James
J
Cunningham
Mark O
MO
Traub
Roger D
RD
Whittington
Miles A
MA
J Neurophysiol. 2003 Nov;90(5):2987-3000
12815025
Conscious Cogn. 2007 Jun;16(2):221-8
16891124
Nat Neurosci. 2000 Sep;3(9):904-10
10966621
Proc Natl Acad Sci U S A. 1985 Sep;82(18):6344-8
3862134
Prog Brain Res. 2004;145:179-96
14650916
Nature. 1996 Oct 17;383(6601):621-4
8857537
Brain Res Brain Res Rev. 1997 Feb;23(1-2):28-46
9063585
J Neurophysiol. 2005 Apr;93(4):2194-232
15525801
Science. 1971 May 7;172(3983):601-2
4324472
Nature. 1999 Nov 4;402(6757):75-9
10573419
Naunyn Schmiedebergs Arch Pharmacol. 1994 Oct;350(4):346-51
7845471
J Neurobiol. 2002 Dec;53(4):633-40
12436426
J Comp Neurol. 2005 Dec 5;493(1):140-6
16254988
Front Cell Neurosci. 2008 Apr 08;2:1
18946516
Ann N Y Acad Sci. 1995 May 10;757:169-79
7611672
Proc Natl Acad Sci U S A. 2004 May 4;101(18):7152-7
15103017
Trends Cogn Sci. 2005 Oct;9(10):474-80
16150631
Curr Opin Neurobiol. 2007 Dec;17(6):649-55
18339546
Trends Neurosci. 1999 Jun;22(6):273-80
10354606
Arch Med Res. 2007 Jan;38(1):52-5
17174723
Metabolism. 2006 Oct;55(10 Suppl 2):S13-9
16979420
Nature. 1993 Jul 1;364(6432):59-60
8316297
Exp Brain Res. 1991;86(3):483-505
1722171
Cereb Cortex. 1999 Mar;9(2):137-50
10220226
Neural Netw. 2008 Oct;21(8):1094-104
18599267
J Neurosci. 1998 Jun 1;18(11):4244-54
9592102
Nature. 1997 Jan 9;385(6612):157-61
8990118
Br J Pharmacol. 2008 Jul;154(5):1104-15
18454168
Science. 1998 Aug 14;281(5379):985-8
9703513
Science. 2007 Jun 15;316(5831):1609-12
17569862
Neurosci Res. 2000 Sep;38(1):19-26
10997574
Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15646-50
17030821
Neuron. 2007 Mar 1;53(5):735-46
17329212
Exp Brain Res. 1992;89(3):611-22
1644125
Annu Rev Neurosci. 1995;18:555-86
7605074
J Physiol. 2004 Jul 15;558(Pt 2):465-78
15146046
Brain Res. 1995 Dec 18;704(2):167-74
8788911
J Neurophysiol. 2007 Jul;98(1):345-59
17493916
Neuropsychopharmacology. 2001 Sep;25(3):313-9
11522460
Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1867-72
10677548
Science. 2005 Sep 30;309(5744):2228-32
16195466
Neuron. 1997 Sep;19(3):679-86
9331357
J Neurosci. 2004 Nov 17;24(46):10369-78
15548651